Prosecution Insights
Last updated: August 18, 2026

Examiner: KIM, DANIELLE A

Tech Center 1600 • Art Units: 1613 1614

This examiner grants 37% of resolved cases

Performance Statistics

36.7%
Allow Rate
-23.3% vs TC avg
171
Total Applications
+57.5%
Interview Lift
1253
Avg Prosecution Days
Based on 90 resolved cases, 2023–2026

Rejection Statute Breakdown

1.1%
§101 Eligibility
6.2%
§102 Novelty
69.1%
§103 Obviousness
16.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17903586 COMPOSITIONS AND METHODS FOR STABILIZING BIOMOLECULES Non-Final OA Massachusetts Institute of Technology
18380984 NanoMesh Drug Delivery for Treatment of Brain Tumors Non-Final OA The Johns Hopkins University
18906308 Compositions Containing a UV-Absorbing System Including Physical UV-Attenuating Material and Oil For Inhibiting Physical UV-Attenuating Material Aggregation Non-Final OA L'OREAL
18544312 PIGMENT DISPERSIONS WITH HYDROPHOBIC POLYMER Final Rejection L'OREAL
17778353 PROCESS FOR TREATING KERATIN FIBERS, COMPRISING A (POLY)CARBODIIMIDE COMPOUND, AN AQUEOUS DISPERSION OF PARTICLES OF POLYMER(S)AND A COLORING AGENT Non-Final OA L'OREAL
17731815 EMULSION COMPOSITIONS COMPRISING A POLYPHENOL AND LOW HLB NONIONIC COMPOUND Non-Final OA L'OREAL
17870228 ACTIVE INGREDIENT-CONTAINING NANOEMULSIONS Non-Final OA NICOVENTURES TRADING LIMITED
18540213 HAIR COSMETIC COMPOSITION Final Rejection KAO CORPORATION
17759703 WATER-IN-OIL EMULSION COSMETIC Final Rejection KAO CORPORATION
18712869 BIOACTIVE CERAMICS CUSTOMIZED FOR TISSUE HEALING AND METHODS FOR PRODUCING SAME Non-Final OA Collagen Matrix, Inc.
17691107 DOSAGE FORMS HAVING EQUIVALENT BIOCOMPARABLE PROFILES Non-Final OA Aquestive Therapeutics, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month